Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/Atorvastatin FDC vs Atorvastatin in Chinese Participants with Hypercholesterolemia
NCT03768427Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co.. Started May 2019; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT03768427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03768427.